Page 4 - Eric Dobmeier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

06/07/23 Life Science Leader Newsletter

Advisory Research Inc. grew its stake in Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) by 7.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 31,101 shares of the company’s stock after acquiring an additional 2,207 shares during the period. Advisory Research Inc.’s holdings in Chinook Therapeutics were worth $815,000 at the end of […]

Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 3,320,000 shares, a growth of 6.1% from the April 15th total of 3,130,000 shares. Approximately 8.0% of the company’s stock are short sold. Based on an average […]

Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) have received an average rating of “Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued ratings on the stock in […]

Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) – Stock analysts at HC Wainwright upped their FY2027 earnings per share (EPS) estimates for shares of Chinook Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per share of […]